Ronny Allan

Ronny Allan is a 3 x award-winning accredited patient leader advocating internationally for Neuroendocrine Cancer and all other cancer patients generally. Check out his Social Media accounts including Facebook, BlueSky, WhatsApp, Instagram and and X.

Background. For those who want a quick run through of Neuroendocrine Tumors from diagnosis to selection of treatment, about the treatments themselves plus what is the Future Directions in the Management of Neuroendocrine Tumors. There are 8 episodes, and each is around 3-5 minutes long. I personally found them very useful and in a language understandable to patients.

Great job by OncLive and Dr Reidy-Lagunes!

Episode 1 - Understanding the Diagnosis and Prognosis of Neuroendocrine Tumors

Diane Reidy-Lagunes, MD, provides an overview of neuroendocrine tumors, along with specific considerations for optimal diagnosis and prognostication.

Understanding the Diagnosis and Prognosis of Neuroendocrine Tumors (onclive.com)

Episode 2 - Neuroendocrine Tumor Pathogenesis and Molecular Testing

Expert insight on the pathogenesis of neuroendocrine tumors and the best use of molecular testing to inform treatment decisions.

Neuroendocrine Tumor Pathogenesis and Molecular Testing (onclive.com)

Episode 3 - An Overview of Treatment Approaches for Neuroendocrine Tumors

Standard treatment pathways for patients with neuroendocrine tumors involving systemic therapy, surgery, and radiation.

An Overview of Treatment Approaches for Neuroendocrine Tumors (onclive.com)

Episode 4 - Neuroendocrine Tumors: Factors That Inform Therapy Selection

A detailed explanation on how disease and patient factors inform selection from the treatment armamentarium for neuroendocrine tumors.

Neuroendocrine Tumors: Factors That Inform Therapy Selection (onclive.com)

Episode 5 - Systemic Therapy for Advanced Neuroendocrine Tumors

Diane Reidy-Lagunes, MD, outlines goals of therapy and selection of systemic therapy for patients with neuroendocrine tumors.

Systemic Therapy for Advanced Neuroendocrine Tumors (onclive.com)

Episode 6 - Advanced Neuroendocrine Tumors: VEGF-Targeted Therapies

Expert reflections on VEGF-targeted therapy’s role in the treatment of patients with neuroendocrine tumors.

Advanced Neuroendocrine Tumors: VEGF-Targeted Therapies (onclive.com)

Episode 7 - Advanced Neuroendocrine Tumors: Clinical Trials With Surufatinib

Considerations for use of surufatinib in patients with neuroendocrine tumors in light of the SANET-p and SANET-ep clinical trials.

Advanced Neuroendocrine Tumors: Clinical Trials With Surufatinib (onclive.com)

Episode 8 - Future Directions in the Management of Neuroendocrine Tumors

Looking toward the future management of neuroendocrine tumors, Diane Reidy-Lagunes, MD, shares insight on possible therapy evolutions and ongoing unmet needs.

Future Directions in the Management of Neuroendocrine Tumors (onclive.com)

Most of this is pretty standard knowledge across the NET Specialist community. One thing I would add is that Dr Reidy-Lagunes talked in at least one of the videos about her own approach to treating NET patients and this may differ in other NET centers.

I hope you enjoyed watching these short but very informative videos?